Patents Assigned to Friedrich Alexander University
  • Flavonoid based antiviral targets
    Patent number: 9629822
    Abstract: The present invention relates to novel compounds for modulating US28 receptor activity and methods for their use in preventing or treating US28 receptor-mediated disorders or conditions.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: April 25, 2017
    Assignees: University of Central Florida Research Foundation, Inc., Friedrich Alexander University
    Inventors: Otto Phanstiel, IV, Nuska Tschammer
  • FLAVONOID BASED ANTIVIRAL TARGETS
    Publication number: 20150209323
    Abstract: The present invention relates to novel compounds for modulating US28 receptor activity and methods for their use in preventing or treating US28 receptor-mediated disorders or conditions.
    Type: Application
    Filed: September 23, 2013
    Publication date: July 30, 2015
    Applicants: University of Central Florida Research Foundation,, Friedrich Alexander University
    Inventors: Otto Phanstiel, IV, Nuska Tschammer
  • Combined immunological agent and sensitizing agent for the treatment of cancer
    Publication number: 20080267977
    Abstract: A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of an apoptosis-inducing immunologic agent, and a sensitizing agent. When used in cancer therapy, the two agents in combination enhance the anti-cancer treatment efficacy obtained with the immunologic agent or the sensitizing agent alone, by a supraadditive amount.
    Type: Application
    Filed: April 26, 2007
    Publication date: October 30, 2008
    Applicant: Friedrich-Alexander University of Erlangen-Nuremberg
    Inventors: Georg H.M. Fey, Julia Stieglmaier, Michael Schwenkert, Michael Schwemmlein